Looking at the importance of an optimistic narrative for science, what’s new in peer review, and how much value is really added by journals.
Featuring the latest tool from Trials Tracker, record profits for Elsevier in 2017 and an introduction to the Open Science Training Handbook.
Does good research require a little rule-breaking? What is in the Delhi Declaration on Open Access? And Sweden’s bold stance on licensing for data sets.
Featuring the natural selection of bad science, a new lease of life for the San Francisco Declaration on Research Assessment, and the growing number of countries standing up to Elsevier.
Featuring PLOS Biology’s vow to publish ‘scooped’ research, a new tool to calculate reproducibility and a study suggesting that academics are more likely than industry scientists to report research misconduct.
At this year’s ISMPP European meeting, a panel of Open Pharma members discussed open access, preprints and post-publication peer review, and the possibility of utilizing these tools to make the publishing of pharmaceutical research faster and more transparent.